- Home
- UFI vs ANVS Comparison
UFI vs ANVS Comparison
Compare UFI & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UFI
- ANVS
- Stock Information
- Founded
- UFI 1969
- ANVS 2008
- Country
- UFI United States
- ANVS United States
- Employees
- UFI N/A
- ANVS N/A
- Industry
- UFI Textiles
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- UFI Consumer Discretionary
- ANVS Health Care
- Exchange
- UFI Nasdaq
- ANVS Nasdaq
- Market Cap
- UFI 123.0M
- ANVS 110.4M
- IPO Year
- UFI N/A
- ANVS 2020
- Fundamental
- Price
- UFI $6.93
- ANVS $7.94
- Analyst Decision
- UFI
- ANVS Strong Buy
- Analyst Count
- UFI 0
- ANVS 5
- Target Price
- UFI N/A
- ANVS $30.60
- AVG Volume (30 Days)
- UFI 56.9K
- ANVS 158.0K
- Earning Date
- UFI 10-30-2024
- ANVS 11-06-2024
- Dividend Yield
- UFI N/A
- ANVS N/A
- EPS Growth
- UFI N/A
- ANVS N/A
- EPS
- UFI N/A
- ANVS N/A
- Revenue
- UFI $582,209,000.00
- ANVS N/A
- Revenue This Year
- UFI $16.88
- ANVS N/A
- Revenue Next Year
- UFI $3.10
- ANVS N/A
- P/E Ratio
- UFI N/A
- ANVS N/A
- Revenue Growth
- UFI N/A
- ANVS N/A
- 52 Week Low
- UFI $5.41
- ANVS $4.53
- 52 Week High
- UFI $7.91
- ANVS $22.49
- Technical
- Relative Strength Index (RSI)
- UFI 51.53
- ANVS 44.61
- Support Level
- UFI $6.64
- ANVS $7.84
- Resistance Level
- UFI $7.04
- ANVS $8.48
- Average True Range (ATR)
- UFI 0.30
- ANVS 0.41
- MACD
- UFI -0.05
- ANVS 0.01
- Stochastic Oscillator
- UFI 48.06
- ANVS 16.09
About UFI Unifi Inc. New
Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.